ATM and gallbladder cancer: Very little information is available regarding the efficacy of PARPi in BTC patients harboring DDR gene mutations, except for a report demonstrating the clinical benefit of olaparib treatment in a gallbladder cancer patient harboring an ATM inactivating mutation [23,52,53].